 bronchial hyperrespons salbutamol year subsensit long-term administr inhal beta bronchial hyperrespons bhr consequ subsensit inhal beta hypothesi group patient asthma chronic obstruct pulmonari diseas experiment group patient microgram salbutamol time year microgram ipratropium time month control group patient opposit treatment regimen bhr respons dose salbutamol number beta antagonist affin receptor lymphocyt start studi interv year bhr year salbutamol valu start studi ipratropium bromid month chang bronchodil respons cumul dose salbutamol chang number affin beta lymphocyt long-term use salbutamol small signific increas bhr increas bhr subsensit beta